Tenon Medical Inc（TNON）财务数据TNONTenon Medical Inc

Evaluating the bottom line, Tenon Medical Inc maintains a gross margin of 68.53%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -237.85%, while the net margin is -252.07%. These profitability ratios, combined with a Return on Equity (ROE) of -558.65%, provide a clear picture of how effectively TNON converts its operational activities into shareholder value.

In the context of the broader market, TNON competes directly with industry leaders such as NIVF and IVF. With a market capitalization of $3.44M, it holds a leading position in the sector. When comparing efficiency, TNON's gross margin of 68.53% stands against NIVF's 36.79% and IVF's 28.37%. Such benchmarking helps identify whether Tenon Medical Inc is trading at a premium or discount relative to its financial performance.

Tenon Medical's financial performance shows a troubling trend with a net loss of $4.05 million in Q2 2026, up from $2.77 million a year earlier. The gross margin has improved to 64%, but the overall financial health remains concerning due to persistent losses.